5-ETHYL-4-(4-METHOXY-PHENYL)-THIAZOL-2-YLAMINE
5-ETHYL-4-(4-METHOXY-PHENYL)-THIAZOL-2-YLAMINE Basic information
- Product Name:
- 5-ETHYL-4-(4-METHOXY-PHENYL)-THIAZOL-2-YLAMINE
- Synonyms:
-
- TIMTEC-BB SBB011699
- 5-ETHYL-4-(4-METHOXY-PHENYL)-THIAZOL-2-YLAMINE
- CBFβ Inhibitor
- 5-ethyl-4-(4-methoxyphenyl)-1,3-thiazol-2-amine
- CBFβ Inhibitor - CAS 493028-20-9 - Calbiochem
- 2-Thiazolamine, 5-ethyl-4-(4-methoxyphenyl)-
- Runx1-CBFβ interaction inhibitor 1
- CBFβInhibitor
- CAS:
- 493028-20-9
- MF:
- C12H14N2OS
- MW:
- 234.32
- Mol File:
- Mol File
5-ETHYL-4-(4-METHOXY-PHENYL)-THIAZOL-2-YLAMINE Chemical Properties
- Boiling point:
- 421.6±40.0 °C(Predicted)
- Density
- 1.192±0.06 g/cm3(Predicted)
- storage temp.
- +2C to +8C
- solubility
- DMF: 50 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 30 mg/ml; Ethanol: 25 mg/ml
- form
- Tan solid
- pka
- 5.00±0.10(Predicted)
Safety Information
- Hazard Codes
- Xi
- HazardClass
- IRRITANT
5-ETHYL-4-(4-METHOXY-PHENYL)-THIAZOL-2-YLAMINE Usage And Synthesis
Description
Core binding factors (CBFs) are heterodimeric transcription factors consisting of a DNA-binding CBFα component (a RUNX protein) and an enhancer of binding, CBFβ. CBF dimers have central roles in hematopoiesis and, when dysfunctional, in leukemias. CBFβ inhibitor is a small molecule that binds to CBFβ and inhibits its association with Runx1 (IC50 = 3.2 μM). It blocks CBFβ-Runx1 interactions in ME-1 cells, acute myeloid leukemia cells harboring dysfunctional CBF, reducing proliferation without toxicity.
Uses
Core binding factors (CBFs) are heterodimeric transcription factors consisting of a DNA-binding CBFα component (a RUNX protein) and an enhancer of binding, CBFβ. CBF dimers have central roles in hematopoiesis and, when dysfunctional, in leukemias. CBFβ inhibitor is a small molecule that binds to CBFβ and inhibits its association with Runx1 (IC50 = 3.2 μM). It blocks CBFβ-Runx1 interactions in ME-1 cells, acute myeloid leukemia cells harboring dysfunctional CBF, reducing proliferation without toxicity.
References
[1] KEVIN A. LINK James C M Fu Sheng Chou. Core binding factor at the crossroads: Determining the fate of the HSC?[J]. Journal of Cellular Physiology, 2009, 222 1: 50-56. DOI: 10.1002/jcp.21950
[2] GEMMA SWIERS Nancy A S Marella de Bruijn. Hematopoietic stem cell emergence in the conceptus and the role of Runx1.[J]. International Journal of Developmental Biology, 2010, 54 6-7: 1151-1163. DOI: 10.1387/ijdb.103106gs
[3] MICHAEL J GORCZYNSKI. Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta.[J]. Chemistry & biology, 2007, 14 10: 1186-1197. DOI: 10.1016/j.chembiol.2007.09.006
5-ETHYL-4-(4-METHOXY-PHENYL)-THIAZOL-2-YLAMINESupplier
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 16314854226
- info@bocsci.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 0519-85528066 13775048983
- sales@hopschem.com
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com